Navigation Links
China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.

LAS VEGAS and BEIJING, Sept. 10 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHL), a development stage company with the goal of becoming a leading diversified global asset holding company and engaged in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy, renewable-energy and finance, today announced that the Company has appointed Mr. Shon as Chairman of the Advisory Board to its wholly-owned subsidiary, China Power, Inc., to assist the Company's strategic development, corporate financing worldwide. Mr. Shon will be given responsibility for corporate finance, investment transactions, and global corporate strategy in both China Holdings, Inc. and China Power, Inc.

Mr. Shon has been the Chairman of Advisory Board of China Holdings, Inc. since early 2007. He is the President of The Shon Group of Companies, a group of privately held real estate investment and development companies which hold the AAA+ Cathedral Office Building in downtown Vancouver, Canada. In addition, Mr. Shon is also the President of China Education Resources Inc., and a director of the Spectra Group of Great Restaurants Inc. Mr. Shon holds a B.A. from Stanford University and a M.B.A. from the Wharton School, University of Pennsylvania.

''Mr. Ronald Shon's extensive successful experiences in investment and transaction advisory services expertise in North America will greatly benefit both CHINA HOLDINGS, INC. and CHINA POWER, INC. as we continue to expand our business. We are very grateful to have Mr. Ronaldson Shon's further valuable contributions to our Companies as the Chairman of Advisory Board,'' said Julianna Lu, the Founder and CEO of both China Holdings, Inc. and China Power, Inc.

About China Holdings, Inc.

China Holdings, Inc. (NASD OTC Bulletin Board: CHHL) is a development stage company with the goal of becoming a diversified global asset holding company. The Company and its subsidiaries engage in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance. Its objective is to achieve long-term capital appreciation through investment in companies and other entities with significant assets, investments, production activities, trading or other business interests in China, and/or worldwide, and/or which derive a significant part of their revenue from China, and/or worldwide.

The Company has two wholly-owned subsidiaries: (i) China Power, Inc., and (ii) China Health Holdings, Inc. For more information, please see the Company's website at: .

About China Power, Inc.

China Power Inc., a wholly owned subsidiary of China Holdings, Inc. (OTCBB: CHHL), is a development stage company with the goal of becoming a global leading energy holding corporation, that focuses on the Merger & Acquisition, investment, Research & Development, construction and operation of energy, and renewable energy, and environment protection projects in China and worldwide. It expects to capture China's growing energy, renewable energy, and environment protection projects domestically and worldwide.

For worldwide investor and media inquiries, please contact:

China Holdings, Inc. (OTCBB: CHHL) and China Power, Inc.

Las Vegas and Beijing

Julianna Lu, Chief Executive Officer, or

James H. Simpson, Senior Vice President/Investor Relations

Tel: +86-10-6586-4770

Fax: +86-10-6586-4790

Mobile: +86-1370-133-1287



Investor Relations International (Los Angeles)

Haris Tajyar

Managing Director

Tel: +1-818-382-9700

Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.

SOURCE China Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
(Date:10/13/2015)... ... , ... Symposium Chairman, Dr. Rod J. Rohrich is pleased to announce that ... March 2nd and 3rd, 2016. The annual meeting, along with the Dallas Rhinoplasty ... around the world. , Key topics at this year's event will include discussions on ...
(Date:10/13/2015)... ... October 13, 2015 , ... Relay (, a ... announced today a significant contract that will provide its award-winning private messaging solution ... on the growing success of its Relay program, IBX Wire™, which now has ...
(Date:10/13/2015)... ... October 13, 2015 , ... NavaFit Inc. today announced the launch of ... train with, participate in local fitness & sporting events, and stay motivated. ... high medical costs drive us to get more serious about fitness and wellness, individuals ...
(Date:10/13/2015)... Boston, MA (PRWEB) , ... October 13, 2015 , ... ... mortar of the body, including muscle, bone, and blood. But how much protein does ... more complicated than it might seem, according to the October 2015 issue of ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... Scientists in ... tissue biopsy in 18 patients with or without mesothelioma. Surviving Mesothelioma has just posted ... , The doctors from PhenoPath Laboratories in Seattle and the University of British Columbia ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015  Data Science Automation (DSA), ... opening of a new branch office in the ... DSA,s presence in Europe . The decision ... increasing demand for local support of customers in the medical ... Ph.D., DSA,s UK Branch Manager. "We have had tremendous success ...
(Date:10/13/2015)... -- SeraCare Life Sciences, a leading partner to global in ... medicine business unit has launched its second product in ... (NGS)-based tumor profiling assays.  The Seraseq TM Solid ... mutations in key oncogenes and tumor suppressor genes as ... is offered at five additional allele frequencies. ...
(Date:10/13/2015)... , Oct. 13, 2015  Graduate students across ... and medical research, will soon have the opportunity ... care – the drug discovery and development process. ... has collaborated with 10 leaders from academic institutions ... Medicines: The Process of Drug Development."  Lilly will ...
Breaking Medicine Technology: